{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:50:31Z","timestamp":1793875831943,"version":"4.7.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T00:00:00Z","timestamp":1709683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["306, SFB841, Heisenberg-Professorship"],"award-info":[{"award-number":["306, SFB841, Heisenberg-Professorship"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Primary sclerosing cholangitis (PSC) is a chronic liver disease marked by inflammation of the bile ducts and results in the development of strictures and fibrosis. A robust clinical correlation exists between PSC and inflammatory bowel disease (IBD). At present, published data are controversial, and it is yet unclear whether IBD drives or attenuates PSC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:italic>Mdr2<\/jats:italic>-deficient mice or DDC-fed mice were used as experimental models for sclerosing cholangitis. Additionally, colitis was induced in mice with experimental sclerosing cholangitis, either through infection with <jats:italic>Citrobacter rodentium<\/jats:italic> or by feeding with DSS. Lastly, fibrosis levels were determined through FibroScan analysis in people with PSC and PSC-IBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Using two distinct experimental models of colitis and two models of sclerosing cholangitis, we found that colitis does not aggravate liver pathology, but rather reduces liver inflammation and liver fibrosis. Likewise, people with PSC-IBD have decreased liver fibrosis compared to those with PSC alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We found evidence that intestinal inflammation attenuates liver pathology. This study serves as a basis for further research on the pathogenesis of PSC and PSC-IBD, as well as the molecular mechanism responsible for the protective effect of IBD on PSC development. This study could lead to the discovery of novel therapeutic targets for PSC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1307297","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T04:39:59Z","timestamp":1709699999000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["A protective effect of inflammatory bowel disease on the severity of sclerosing cholangitis"],"prefix":"10.3389","volume":"15","author":[{"given":"Friederike","family":"Stumme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babett","family":"Steglich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Mathies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikolaj","family":"Nawrocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morsal","family":"Sabihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwa","family":"Soukou-Wargalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"G\u00f6ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kempski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorben","family":"Fr\u00fcndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f6ren","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Gagliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Bedke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30300-3","article-title":"Primary sclerosing cholangitis","volume":"391","author":"Dyson","year":"2018","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"crossref","DOI":"10.1136\/gut.21.10.870","article-title":"Primary sclerosing cholangitis: A review of its clinical features, cholangiography, and hepatic histology","volume":"21","author":"Chapman","year":"1980","journal-title":"Gut"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2004.046615","article-title":"Psc-ibd: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Loftus","year":"2005","journal-title":"Gut"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izad137","article-title":"A gradient of intestinal inflammation in primary sclerosing cholangitis","author":"Wittek","year":"2023","journal-title":"Inflammation Bowel Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC-IBD","volume":"20","author":"Ricciuto","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-310500","article-title":"The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls","volume":"66","author":"Kummen","year":"2017","journal-title":"Gut"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"B10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12072-020-10089-z","article-title":"Alterations of the salivary and fecal microbiome in patients with primary sclerosing cholangitis","volume":"15","author":"Lapidot","year":"2021","journal-title":"Hepatol Int"},{"key":"B11","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jaci.2019.11.003","article-title":"The microbiome and inflammatory bowel disease","volume":"145","author":"Glassner","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"237ra66","DOI":"10.1126\/scitranslmed.3008618","article-title":"The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota","volume":"6","author":"Balmer","year":"2014","journal-title":"Sci Transl Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800711","article-title":"Colitis promotes a pathological condition of the liver in the absence of foxp3","volume":"201","author":"Mathies","year":"2018","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat Microbiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041035","article-title":"Hepatic endothelial CCL25 mediates the recruitment of CCR9+ Gut-homing lymphocytes to the liver in primary sclerosing cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J Exp Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1053\/j.gastro.2014.04.003","article-title":"Loss of cd28 expression by liver-infiltrating T cells contributes to pathogenesis of primary sclerosing cholangitis","volume":"147","author":"Liaskou","year":"2014","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26702","article-title":"Cd8 T cells primed in the gut-associated lymphoid tissue induce immune-mediated cholangitis in mice","volume":"59","author":"Seidel","year":"2014","journal-title":"Hepatol (Baltimore Md)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1038\/s41467-023-38840-8","article-title":"Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis","volume":"14","author":"Gui","year":"2023","journal-title":"Nat Commun"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.02.035","article-title":"Dss induced colitis increases portal lps levels and enhances hepatic inflammation and fibrogenesis in experimental nash","volume":"55","author":"G\u00e4bele","year":"2011","journal-title":"J Hepatol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/cells9020341","article-title":"Metabolomic analysis of the liver of a dextran sodium sulfate-induced acute colitis mouse model: implications of the gut-liver connection","volume":"9","author":"Kim","year":"2020","journal-title":"Cells"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.023","article-title":"Transient elastography in autoimmune hepatitis: timing determines the impact of inflammation and fibrosis","volume":"65","author":"Hartl","year":"2016","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-311452","article-title":"Spleen size for the prediction of clinical outcome in patients with primary sclerosing cholangitis","volume":"65","author":"Ehlken","year":"2016","journal-title":"Gut"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah5903","article-title":"A pathogenic role for T cell-derived il-22bp in inflammatory bowel disease","volume":"354","author":"Pelczar","year":"2016","journal-title":"Science"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.446","article-title":"High resolution colonoscopy in live mice","volume":"1","author":"Becker","year":"2006","journal-title":"Nat Protoc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.02.006","article-title":"Characterization of animal models for primary sclerosing cholangitis (Psc)","volume":"60","author":"Fickert","year":"2014","journal-title":"J Hepatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-009-0154-7","article-title":"The immunobiology of primary sclerosing cholangitis","volume":"31","author":"Aron","year":"2009","journal-title":"Semin Immunopathol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2003.12.045","article-title":"Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis","volume":"126","author":"Siller-L\u00f3pez","year":"2004","journal-title":"Gastroenterology"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3315","article-title":"Citrobacter rodentium: infection, inflammation and the microbiota","volume":"12","author":"Collins","year":"2014","journal-title":"Nat Rev Microbiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2003.03333.x","article-title":"Immune response in mouse experimental cholangitis associated with colitis induced by dextran sulfate sodium","volume":"19","author":"Numata","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1136\/gut.21.10.870","article-title":"Primary sclerosing cholangitis, part 1: epidemiology, etiopathogenesis, clinical features, and treatment","volume":"14","author":"Tabibian","year":"2018","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.10.011","article-title":"The dynamic biliary epithelia: molecules, pathways, and disease","volume":"58","author":"O'Hara","year":"2013","journal-title":"J Hepatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000604","article-title":"Targeting the gut microbiome as a treatment for primary sclerosing cholangitis: A conceptional framework","volume":"115","author":"Shah","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-021-00452-1","article-title":"Gut microbiota depletion exacerbates cholestatic liver injury via loss of fxr signalling","volume":"3","author":"Schneider","year":"2021","journal-title":"Nat Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.12.027","article-title":"Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease","volume":"11","author":"J\u00f8rgensen","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.07.005","article-title":"Risk factors for recurrent primary sclerosing cholangitis after liver transplantation","volume":"63","author":"Ravikumar","year":"2015","journal-title":"J Hepatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/00365521.2017.1421705","article-title":"Risk factors and prognosis for recurrent primary sclerosing cholangitis after liver transplantation: A nordic multicentre study","volume":"53","author":"Lindstr\u00f6m","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14393","article-title":"Colectomy prior to diagnosis of primary sclerosing cholangitis is associated with improved prognosis in a nationwide cohort study of 2594 PSC-IBD patients","volume":"47","author":"Nordenvall","year":"2018","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1307297\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T04:40:04Z","timestamp":1709700004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1307297\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,6]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2024.1307297"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1307297","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,6]]},"article-number":"1307297"}}